Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 202

The DOI matches its Crossref record.

Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy

Open access
Marcus, Gregory M., Glidden, David V., Polonsky, Bronislava, Zareba, Wojciech, Smith, Lisa M., Cannom, David S., Estes, N.A. Mark, Marcus, Frank, Scheinman, Melvin M. · 2009 · Journal of the American College of Cardiology

Abstract

Background Antiarrhythmic drugs are important in protecting against ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy (ARVC), but no studies have provided data in a group rigorously screened for the disease. Objective To examine the efficacy of empiric antiarrhythmic drugs in a rigorously characterized cohort of ARVC patients. Methods Antiarrhythmic medicines were examined in all subjects with implantable cardioverter-defibrillators (ICDs) enrolled in the North American ARVC/D Registry. A Cox proportional hazards model was used to account for time on each drug, and a hierarchical analysis was performed for repeated measures within individuals. Results Ninety-five patients were studied, with a mean follow-up of 480 ± 389 days. Fifty-eight (61%) received beta-blockers, and these medicines were not associated with an increased or decreased risk of ventricular arrhythmias. Sotalol was associated with a greater risk of any clinically relevant ventricular arrhythmia as defined by sustained ventricular tachycardia or ICD therapy (hazard ratio [HR] 2.55, 95% CI 1.02–6.39, p=0.045), but this was not statistically significant after adjusting for potential confounders. An increased risk of any ICD shock and first clinically relevant ventricular arrhythmia while on sotalol remained significant after multivariable adjustment. Those on amiodarone (n=10) had a significantly lower risk of any clinically relevant ventricular arrhythmia (HR 0.25, 95% CI 0.07–0.95, p=0.041), a finding that remained significant after multivariable adjustment. Conclusion In a cohort of well characterized ARVC subjects, neither beta-blockers nor sotalol appeared to be protective. Evidence from a small number of patients suggests that amiodarone has superior efficacy in preventing ventricular arrhythmias.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.04.052

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 202

Metadata

Authors
Marcus, G. M., Glidden, D. V., Polonsky, B., Zareba, W., Smith, L. M., Cannom, D. S., Estes, N. A. M., Marcus, F., & Scheinman, M. M.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2009-08
Volume
54
Issue
7
Pages
609-615
ISSN
0735-1097 (ISSN-L)
OpenAlex
W1592800897
Cited by
202
References
0
FWCI
5.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy. https://app.cochat.ai/papers/10.1016/j.jacc.2009.04.052
The paper
Marcus, G. M., Glidden, D. V., Polonsky, B., Zareba, W., Smith, L. M., Cannom, D. S., Estes, N. A. M., Marcus, F., & Scheinman, M. M. (2009). Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2009.04.052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.